BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

875 related articles for article (PubMed ID: 18564660)

  • 21. Secondary prophylaxis of hepatic encephalopathy in cirrhosis: an open-label, randomized controlled trial of lactulose, probiotics, and no therapy.
    Agrawal A; Sharma BC; Sharma P; Sarin SK
    Am J Gastroenterol; 2012 Jul; 107(7):1043-50. PubMed ID: 22710579
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Minimal hepatic encephalopathy: characteristics, diagnosis and clinical implications].
    Torre Delgadillo A; Guerrero-Hernández I; Uribe M
    Rev Gastroenterol Mex; 2006; 71(1):63-70. PubMed ID: 17061481
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessment of low-grade hepatic encephalopathy: a critical analysis.
    Kircheis G; Fleig WE; Görtelmeyer R; Grafe S; Häussinger D
    J Hepatol; 2007 Nov; 47(5):642-50. PubMed ID: 17869373
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Primary prophylaxis of overt hepatic encephalopathy in patients with cirrhosis: an open labeled randomized controlled trial of lactulose versus no lactulose.
    Sharma P; Sharma BC; Agrawal A; Sarin SK
    J Gastroenterol Hepatol; 2012 Aug; 27(8):1329-35. PubMed ID: 22606978
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatic encephalopathy: pathophysiology and advances in therapy.
    Av SP
    Trop Gastroenterol; 2007; 28(1):4-10. PubMed ID: 17896602
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Hepatic encephalopathy: neuropsychological and neurophysiological diagnosis].
    Kuhlbusch R; Enck P; Häussinger D
    Z Gastroenterol; 1998 Dec; 36(12):1075-83. PubMed ID: 10025059
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The diagnosis of subclinical hepatic encephalopathy].
    Słowik A; Ciećko-Michalska I; Bogdał J; Szczudlik A
    Przegl Lek; 2001; 58(12):1059-62. PubMed ID: 12041022
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Noncirrhotic portal vein thrombosis exhibits neuropsychological and MR changes consistent with minimal hepatic encephalopathy.
    Mínguez B; García-Pagán JC; Bosch J; Turnes J; Alonso J; Rovira A; Córdoba J
    Hepatology; 2006 Apr; 43(4):707-14. PubMed ID: 16557541
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The diagnosis of subclinical hepatic encephalopathy in patients with cirrhosis using neuropsychological tests and automated electroencephalogram analysis.
    Quero JC; Hartmann IJ; Meulstee J; Hop WC; Schalm SW
    Hepatology; 1996 Sep; 24(3):556-60. PubMed ID: 8781324
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Minimal hepatic encephalopathy.
    Stewart CA; Smith GE
    Nat Clin Pract Gastroenterol Hepatol; 2007 Dec; 4(12):677-85. PubMed ID: 18043677
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Critical flicker frequency: diagnostic tool for minimal hepatic encephalopathy.
    Sharma P; Sharma BC; Puri V; Sarin SK
    J Hepatol; 2007 Jul; 47(1):67-73. PubMed ID: 17459511
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Review article: the modern management of hepatic encephalopathy.
    Bajaj JS
    Aliment Pharmacol Ther; 2010 Mar; 31(5):537-47. PubMed ID: 20002027
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Psychometric hepatic encephalopathy score for the detection of minimal hepatic encephalopathy in Korean patients with liver cirrhosis.
    Seo YS; Yim SY; Jung JY; Kim CH; Kim JD; Keum B; An H; Yim HJ; Lee HS; Kim CD; Ryu HS; Um SH
    J Gastroenterol Hepatol; 2012 Nov; 27(11):1695-704. PubMed ID: 22743001
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic value of altered oral glutamine challenge in patients with minimal hepatic encephalopathy.
    Romero-Gómez M; Grande L; Camacho I
    Hepatology; 2004 Apr; 39(4):939-43. PubMed ID: 15057897
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Encephalopathy assessment in children with extra-hepatic portal vein obstruction with MR, psychometry and critical flicker frequency.
    Yadav SK; Srivastava A; Srivastava A; Thomas MA; Agarwal J; Pandey CM; Lal R; Yachha SK; Saraswat VA; Gupta RK
    J Hepatol; 2010 Mar; 52(3):348-54. PubMed ID: 20137823
    [TBL] [Abstract][Full Text] [Related]  

  • 36. P300 latency for the diagnosis of minimal hepatic encephalopathy: evidence that spectral EEG analysis and psychometric tests are enough.
    Amodio P; Valenti P; Del Piccolo F; Pellegrini A; Schiff S; Angeli P; Poci C; Mapelli D; Iannizzi P; Gatta A
    Dig Liver Dis; 2005 Nov; 37(11):861-8. PubMed ID: 16183341
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A randomized double blind placebo controlled trial of probiotics in minimal hepatic encephalopathy.
    Saji S; Kumar S; Thomas V
    Trop Gastroenterol; 2011; 32(2):128-32. PubMed ID: 21922877
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical efficacy and safety of lactulose for minimal hepatic encephalopathy: a meta-analysis.
    Luo M; Li L; Lu CZ; Cao WK
    Eur J Gastroenterol Hepatol; 2011 Nov; 23(12):1250-7. PubMed ID: 21971378
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evolving concepts: the negative effect of minimal hepatic encephalopathy and role for prophylaxis in patients with cirrhosis.
    Prakash RK; Kanna S; Mullen KD
    Clin Ther; 2013 Sep; 35(9):1458-73. PubMed ID: 23972578
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lactulose improves cognitive functions and health-related quality of life in patients with cirrhosis who have minimal hepatic encephalopathy.
    Prasad S; Dhiman RK; Duseja A; Chawla YK; Sharma A; Agarwal R
    Hepatology; 2007 Mar; 45(3):549-59. PubMed ID: 17326150
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 44.